Zobrazeno 1 - 10
of 106
pro vyhledávání: '"Tasian SK"'
Autor:
Pearson, ADJ, Zwaan, C.M., Kolb, EA, Karres, D, Guillot, J, Kim, SY, Marshall, L, Tasian, SK, Smith, M, Cooper, T, Adamson, PC, Barry, E, Benettaib, B, Binlich, F, Borgman, A, Brivio, E, Capdeville, R, Delgado, D, Faller, DV, Fogelstrand, L, Fraenkel, PG, Hasle, H, Heenen, D, Kaspers, G, Kieran, M, Klusmann, JH, Lesa, G, Ligas, F, Mappa, S, Mohamed, H, Moore, A, Morris, J, Nottage, K, Reinhardt, D, Scobie, N, Simko, S, Winkler, T, Norga, K, Reaman, G, Vassal, G
Publikováno v:
European journal of cancer
Pearson, A D J, Zwaan, C M, Kolb, E A, Karres, D, Guillot, J, Kim, S Y, Marshall, L, Tasian, S K, Smith, M, Cooper, T, Adamson, P C, Barry, E, Benettaib, B, Binlich, F, Borgman, A, Brivio, E, Capdeville, R, Delgado, D, Faller, D V, Fogelstrand, L, Fraenkel, P G, Hasle, H, Heenen, D, Kaspers, G, Kieran, M, Klusmann, J H, Lesa, G, Ligas, F, Mappa, S, Mohamed, H, Moore, A, Morris, J, Nottage, K, Reinhardt, D, Scobie, N, Simko, S, Winkler, T, Norga, K, Reaman, G & Vassal, G 2020, ' Paediatric Strategy Forum for medicinal product development for acute myeloid leukaemia in children and adolescents : ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration ', European Journal of Cancer, vol. 136, pp. 116-129 . https://doi.org/10.1016/j.ejca.2020.04.038
European Journal of Cancer, 136, 116-129. Pergamon
European Journal of Cancer, 136, 116-129. Elsevier Ltd.
Pearson, A D J, Zwaan, C M, Kolb, E A, Karres, D, Guillot, J, Kim, S Y, Marshall, L, Tasian, S K, Smith, M, Cooper, T, Adamson, P C, Barry, E, Benettaib, B, Binlich, F, Borgman, A, Brivio, E, Capdeville, R, Delgado, D, Faller, D V, Fogelstrand, L, Fraenkel, P G, Hasle, H, Heenen, D, Kaspers, G, Kieran, M, Klusmann, J H, Lesa, G, Ligas, F, Mappa, S, Mohamed, H, Moore, A, Morris, J, Nottage, K, Reinhardt, D, Scobie, N, Simko, S, Winkler, T, Norga, K, Reaman, G & Vassal, G 2020, ' Paediatric Strategy Forum for medicinal product development for acute myeloid leukaemia in children and adolescents : ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration ', European Journal of Cancer, vol. 136, pp. 116-129 . https://doi.org/10.1016/j.ejca.2020.04.038
European Journal of Cancer, 136, 116-129. Pergamon
European Journal of Cancer, 136, 116-129. Elsevier Ltd.
Purpose: The current standard-of-care for front-line therapy for acute myeloid leukaemia (AML) results in short-term and long-term toxicity, but still approximately 40% of children relapse. Therefore, there is a major need to accelerate the evaluatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::ea901e797ad2961db6c39007f2797adc
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85087974955
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85087974955
Autor:
Torres-Diz M; Division of Cancer Pathobiology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania., Reglero C; Institute for Cancer Genetics, Columbia University, New York, New York., Falkenstein CD; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania., Castro A; Division of Cancer Pathobiology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania., Hayer KE; Division of Cancer Pathobiology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.; Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania., Radens CM; Cell and Molecular Biology Graduate Group, University of Pennsylvania, Philadelphia, Pennsylvania.; Department of Genetics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania., Quesnel-Vallières M; Department of Genetics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania., Ang Z; Division of Cancer Pathobiology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania., Sehgal P; Division of Cancer Pathobiology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania., Li MM; Division of Genomic Diagnostic, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania., Barash Y; Cell and Molecular Biology Graduate Group, University of Pennsylvania, Philadelphia, Pennsylvania.; Department of Genetics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania., Tasian SK; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.; Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania., Ferrando A; Institute for Cancer Genetics, Columbia University, New York, New York.; Department of Pediatrics, Columbia University, New York, New York., Thomas-Tikhonenko A; Division of Cancer Pathobiology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.; Cell and Molecular Biology Graduate Group, University of Pennsylvania, Philadelphia, Pennsylvania.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.; Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
Publikováno v:
Cancer research [Cancer Res] 2024 Oct 15; Vol. 84 (20), pp. 3327-3336.
Autor:
Cuglievan B; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. bcuglievan@mdanderson.org., Kantarjian H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Rubnitz JE; Department of Oncology, St Jude Children's Research Hospital, Memphis, TN, USA., Cooper TM; Cancer and Blood Disorders Center, Seattle Children's Hospital, University of Washington, Seattle, WA, USA., Zwaan CM; Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands; Pediatric Oncology, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands; The Innovative Therapies for Children with Cancer Consortium, Paris, France., Pollard JA; Department of Pediatrics, Harvard Medical School, Boston, MA, USA., DiNardo CD; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kadia TM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Guest E; Department of Pediatric Oncology, Children's Mercy, Kansas City, MO, USA., Short NJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., McCall D; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Daver N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Nunez C; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Haddad FG; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Garcia M; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Bhalla KN; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Maiti A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Catueno S; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Fiskus W; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Carter BZ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gibson A; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Roth M; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Khazal S; Division of Transplant and Cellular Therapy, Loma Linda University School of Medicine, Loma Linda, CA, USA., Tewari P; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer, Houston, TX, USA., Abbas HA; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Bourgeois W; Department of Pediatrics, Harvard Medical School, Boston, MA, USA., Andreeff M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Shukla NN; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Truong DD; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Connors J; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer, Houston, TX, USA., Ludwig JA; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Stutterheim J; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Salzer E; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Juul-Dam KL; Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark., Sasaki K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Mahadeo KM; Division of Pediatric Transplantation and Cellular Therapy, Duke University, Durham, NC, USA., Tasian SK; Department of Pediatrics and Abramson Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, PA, USA., Borthakur G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Dickson S; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Jain N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Jabbour E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Meshinchi S; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Stein EM; Department of Leukemia, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Kolb EA; Moseley Institute for Cancer and Blood Disorders, Nemours Children's Health, Wilmington, DE, USA., Issa GC; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Publikováno v:
Leukemia [Leukemia] 2024 Oct; Vol. 38 (10), pp. 2073-2084. Date of Electronic Publication: 2024 Aug 23.
Autor:
Elitzur S; Department of Pediatric Hematology and Oncology, Schneider Children's Medical Center and Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Shiloh R; Department of Pediatric Hematology and Oncology, Schneider Children's Medical Center and Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; Felsenstein Medical Research Center, Faculty of Medicine, Tel Aviv University, Petah Tikva, Israel., Loeffen JLC; Department of Hemato-Oncology, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Pastorczak A; Department of Pediatrics, Oncology and Hematology, and Department of Genetic Predisposition to Cancer, Medical University of Lodz, Lodz, Poland., Takagi M; Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University, Tokyo, Japan., Bomken S; Wolfson Childhood Cancer Research Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, United Kingdom., Baruchel A; Department of Pediatric Hemato-Immunology, Hôpital Robert Debré, Paris, France., Lehrnbecher T; Division of Hematology, Oncology and Hemostaseology, Department of Pediatrics, Goethe University Frankfurt, Frankfurt/Main, Germany., Tasian SK; Division of Oncology and Center for Childhood Cancer Research, Department of Pediatrics and Abramson Cancer Center, University of Pennsylvania School of Medicine and Children's Hospital of Philadelphia, Philadelphia, PA., Abla O; Division of Hematology/Oncology, Hospital For Sick Children, Toronto, ON, Canada., Arad-Cohen N; Department of Pediatric Hemato-Oncology, Rambam Health Care Campus, Haifa, Israel., Astigarraga I; Pediatrics Department, Hospital Universitario Cruces, Osakidetza, Pediatric Oncology Group, Bizkaia Health Research Institute, Pediatric Department, Universidad del País Vasco UPV/EHU, Barakaldo, Spain., Ben-Harosh M; Department of Pediatric Hematology-Oncology, Soroka Medical Center, Beer Sheva, Israel., Bodmer N; Department of Oncology, University Children's Hospital Zurich, Zurich, Switzerland., Brozou T; Department of Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Heinrich Heine University Duesseldorf, Duesseldorf, Germany., Ceppi F; Division of Pediatrics, Pediatric Hematology-Oncology Unit, University Hospital of Lausanne and University of Lausanne, Lausanne, Switzerland., Chugaeva L; Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation., Dalla Pozza L; Cancer Centre for Children, The Children's Hospital at Westmead, Westmead, NSW, Australia., Ducassou S; Department of Pediatric Hemato-Oncology, CHU Bordeaux, Bordeaux, France., Escherich G; Clinic of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Farah R; Department of Pediatrics and Pediatric Hematology/Oncology, Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese American University, Beirut, Lebanon., Gibson A; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX., Hasle H; Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark., Hoveyan J; Pediatric Cancer and Blood Disorders Center of Armenia, Yeolyan Hematology and Oncology Center and Immune Oncology Research Institute, Yerevan, Armenia., Jacoby E; Department of Pediatric Hematology-Oncology, Safra Children's Hospital, Sheba Medical Center and Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Jazbec J; Department of Pediatric Hematology and Oncology, University Children's Hospital, Faculty of Medicine, University of Ljubljan, Ljubljana, Slovenia., Junk S; Department of Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Heinrich Heine University Duesseldorf, Duesseldorf, Germany., Kolenova A; Department of Pediatric Hematology and Oncology, National Institute of Children's Diseases, Comenius University Children's Hospital, Bratislava, Slovakia., Lazic J; Department of Hematology and Oncology, University Children's Hospital, School of Medicine University of Belgrade, Belgrade, Serbia., Lo Nigro L; Azienda Policlinico, San Marco, Center of Pediatric Hematology Oncology, Catania, Italy., Mahlaoui N; Immuno-Haematology and Rheumatology Unit, Necker Enfants Malades University Hospital, Assistance Publique-Hôpitaux de Paris, French National Reference Center for Primary Immune Deficiencies, Necker Enfants Malades University Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France., Miller L; Cancers and Blood Disorders Program, Children's Minnesota, Minneapolis, MN., Papadakis V; Department of Pediatric Hematology-Oncology, Agia Sofia Children's Hospital, Athens, Greece., Pecheux L; Department of Pediatric Hematology-Oncology, Stollery Children Hospital, University of Alberta, Edmonton, Canada., Pillon M; Pediatric Hematology, Oncology and Stem Cell Transplant Center, University of Padua, Padua, Italy., Sarouk I; Pediatric Pulmonology Unit and Ataxia Telangiectasia Center, The Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Ramat Gan, Israel., Stary J; Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University, University Hospital Motol, Prague, Czech Republic., Stiakaki E; Department of Pediatric Hematology-Oncology, University Hospital of Heraklion, Heraklion Crete, Greece., Strullu M; Department of Pediatric Hemato-Immunology, Hôpital Robert Debré, Paris, France., Tran TH; Division of Pediatric Hematology Oncology, CHU Sainte Justine, Montreal, QC, Canada., Ussowicz M; Clinical Department of Paediatric Bone Marrow Transplantation, Oncology and Haematology, Wroclaw Medical University, Wroclaw, Poland., Verdu-Amoros J; Department of Pediatric Hematology and Oncology, University Hospital Valencia, INCLIVA Biomedical Research Institute, Valencia, Spain., Wakulinska A; Department of Oncology, The Children's Memorial Health Institute, Warsaw, Poland., Zawitkowska J; Department of Pediatric Hematology, Oncology and Transplantation, Medical University of Lublin, Lublin, Poland., Stoppa-Lyonnet D; Department of Genetics, Institut Curie, INSERM U830, and Université Paris Cité, Paris, France., Taylor AM; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom., Shiloh Y; Department of Human Molecular Genetics and Biochemistry, Tel Aviv University School of Medicine, Tel Aviv, Israel., Izraeli S; Department of Pediatric Hematology and Oncology, Schneider Children's Medical Center and Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Minard-Colin V; Department of Pediatric and Adolescent Oncology, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France., Schmiegelow K; Department of Pediatrics and Adolescent Medicine, Rigshospitalet University Hospital, Copenhagen, Denmark., Nirel R; Department of Statistics and Data Science, Hebrew University, Jerusalem, Israel., Attarbaschi A; Department of Pediatric Hematology and Oncology, St Anna Children's Hospital, Medical University of Vienna, Vienna, Austria.; St Anna Children's Cancer Research Institute, Vienna, Austria., Borkhardt A; Department of Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Heinrich Heine University Duesseldorf, Duesseldorf, Germany.
Publikováno v:
Blood [Blood] 2024 Sep 12; Vol. 144 (11), pp. 1193-1205.
Autor:
Stieglitz E; Department of Pediatrics, Benioff Children's Hospitals, University of California San Francisco, San Francisco, California., Lee AG; Department of Pediatrics, Benioff Children's Hospitals, University of California San Francisco, San Francisco, California., Angus SP; Department of Pediatrics, Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, Indiana., Davis C; Department of Pediatrics, Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, Indiana., Barkauskas DA; Children Oncology Group Operations and Data Center, Monrovia, California., Hall D; Children Oncology Group Operations and Data Center, Monrovia, California., Kogan SC; Department of Laboratory Medicine, University of California San Francisco, San Francisco, California., Meyer J; Department of Pediatrics, Benioff Children's Hospitals, University of California San Francisco, San Francisco, California., Rhodes SD; Department of Pediatrics, Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, Indiana.; Division of Pediatric Hematology-Oncology, Indiana University School of Medicine, Indianapolis, Indiana., Tasian SK; Children's Hospital of Philadelphia, Division of Oncology and Center for Childhood Cancer Research and University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania., Xuei X; Department of Pediatrics, Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, Indiana., Shannon K; Department of Pediatrics, Benioff Children's Hospitals, University of California San Francisco, San Francisco, California., Loh ML; Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute and Department Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, Washington., Fox E; St. Jude Children's Research Hospital, Memphis, Tennessee., Weigel BJ; University of Minnesota, Minneapolis, Minnesota.
Publikováno v:
Cancer discovery [Cancer Discov] 2024 Sep 04; Vol. 14 (9), pp. 1590-1598.
Autor:
Newman H; Division of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Clark ME; Division of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA., Wong D; Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, PA., Wu J; Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, PA., Brodeur GM; Division of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA., Hunger SP; Division of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA., Tasian SK; Division of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA., Olson T; Division of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA., Warren JT; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; Division of Hematology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA., Teachey DT; Division of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA., Bona K; Department of Pediatric Oncology, Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA., Schubert J; Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, PA., Golenberg N; Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, PA., Patel M; Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, PA., Denenberg EH; Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, PA., Fanning EA; Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, PA., Chen J; Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, PA., Luke T; Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, PA., Charles S; Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, PA., Gallo D; Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, PA., Cao K; Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, PA., Fu W; Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, PA., Fan Z; Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, PA., Surrey LF; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, PA., Wertheim G; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, PA., Luo M; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, PA., MacFarland SP; Division of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA., Li MM; Division of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, PA., Zhong Y; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, PA. zhongy1@chop.edu.
Publikováno v:
Haematologica [Haematologica] 2024 Sep 01; Vol. 109 (9), pp. 3024-3030. Date of Electronic Publication: 2024 Sep 01.
Autor:
Hill TF; University of Washington, Medical Scientist Training Program, Seattle, WA, USA; Seattle Children's Research Institute, Center for Immunity and Immunotherapy, Seattle, WA, USA., Narvekar P; Seattle Children's Research Institute, Center for Immunity and Immunotherapy, Seattle, WA, USA., Asher GD; Seattle Children's Research Institute, Center for Immunity and Immunotherapy, Seattle, WA, USA., Edelstein JN; BE Biopharma, Cambridge, MA, USA., Camp ND; Seattle Children's Research Institute, Center for Immunity and Immunotherapy, Seattle, WA, USA., Grimm A; Seattle Children's Research Institute, Center for Immunity and Immunotherapy, Seattle, WA, USA., Thomas KR; Seattle Children's Research Institute, Center for Immunity and Immunotherapy, Seattle, WA, USA., Leiken MD; BE Biopharma, Cambridge, MA, USA., Molloy KM; BE Biopharma, Cambridge, MA, USA., Cook PJ; Seattle Children's Research Institute, Center for Immunity and Immunotherapy, Seattle, WA, USA., Arlauckas SP; BE Biopharma, Cambridge, MA, USA., Morgan RA; BE Biopharma, Cambridge, MA, USA., Tasian SK; Children's Hospital of Philadelphia, Division of Oncology and Center for Childhood Cancer Research, Philadelphia, PA, USA; Department of Pediatrics and Abramson Cancer Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Rawlings DJ; Seattle Children's Research Institute, Center for Immunity and Immunotherapy, Seattle, WA, USA; University of Washington, Departments of Pediatrics and Immunology, Seattle, WA, USA., James RG; Seattle Children's Research Institute, Center for Immunity and Immunotherapy, Seattle, WA, USA; University of Washington, Departments of Pediatrics and Pharmacology, Seattle, WA, USA. Electronic address: richard.james@seattlechildrens.org.
Publikováno v:
Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2024 Aug 07; Vol. 32 (8), pp. 2676-2691. Date of Electronic Publication: 2024 Jul 02.
Autor:
Wintering A; Department of Pediatrics, Benioff Children's Hospitals, University of California San Francisco, San Francisco, CA 94158., Hecht A; Department of Hematology/Oncology, Klinikum Rechts der Isar, Technische Universität München, München., Meyer J; Department of Pediatrics, Benioff Children's Hospitals, University of California San Francisco, San Francisco, CA 94158., Wong EB; Department of Pediatrics, Benioff Children's Hospitals, University of California San Francisco, San Francisco, CA 94158., Hübner J; Department of Pediatrics, Benioff Children's Hospitals, University of California San Francisco, San Francisco, CA 94158., Abelson S; Department of Pediatrics, Benioff Children's Hospitals, University of California San Francisco, San Francisco, CA 94158., Feldman K; Department of Pediatrics, Benioff Children's Hospitals, University of California San Francisco, San Francisco, CA 94158., Kennedy VE; Division of Hematology/Oncology, Department of Medicine, University of California San Francisco, San Francisco, CA 94158., Peretz CAC; Helen Diller Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA 94158., French DL; Center for Cellular and Molecular Therapeutics, The Children's Hospital of Philadelphia, Philadelphia, PA 19104., Maguire JA; Center for Cellular and Molecular Therapeutics, The Children's Hospital of Philadelphia, Philadelphia, PA 19104., Jobaliya C; Center for Cellular and Molecular Therapeutics, The Children's Hospital of Philadelphia, Philadelphia, PA 19104., Vasquez MR; Department of Pediatrics, University of Alberta, Edmonton, AB T6G 1C9, Canada., Desai S; Department of Pediatrics, University of Alberta, Edmonton, AB T6G 1C9, Canada., Dulman R; Pediatric Hematology and Oncology, Pediatric Specialists of Virginia, Fairfax, VA 22031., Nemecek E; OHSU Knight Cancer Institute, Oregon Health and Science University, Portland, OR 97239., Haines H; Children's of Alabama, University of Alabama Hospital, Birmingham, AL 35233., Hammad M; National Cancer Institute, Cairo University, Cairo, Egypt., El Haddad A; National Cancer Institute, Cairo University, Cairo, Egypt., Kogan SC; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA 94158., Abdullaev Z; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20814., Chehab FF; Institute for Human Genetics, University of California San Francisco, San Francisco, CA 94143., Tasian SK; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia; Philadelphia, PA 19104, USA; Department of Pediatrics and Abramson Cancer Center, University of Pennsylvania Perelman School of Medicine; Philadelphia, PA 19104., Smith CC; Division of Hematology/Oncology, Department of Medicine, University of California San Francisco, San Francisco, CA 94158, USA; Helen Diller Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA 94158., Loh ML; Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute, and the Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, WA, 98105. mignon.loh@seattlechildrens.org., Stieglitz E; Department of Pediatrics, Benioff Children's Hospitals, University of California San Francisco, San Francisco, CA 94158, USA; Helen Diller Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA 94158. elliot.stieglitz@ucsf.edu.
Publikováno v:
Haematologica [Haematologica] 2024 Aug 01; Vol. 109 (8), pp. 2533-2541. Date of Electronic Publication: 2024 Aug 01.
Autor:
van Outersterp I; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Tasian SK; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA., Reichert CEJ; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Boeree A; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., de Groot-Kruseman HA; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Escherich G; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg Eppendorf, Hamburg, Germany., Boer JM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., den Boer ML; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Pediatric Oncology and Hematology, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands.
Publikováno v:
Blood [Blood] 2024 May 23; Vol. 143 (21), pp. 2178-2189.